Lupin Limited has informed the Exchange regarding a press release dated May 27, 2021, titled "Lupin Announces Achievement of Key Milestones for its Clinical Stage MEK Inhibitor Compound.".
Lupin Limited has informed the Exchange regarding a press release dated May 27, 2021, titled "Lupin Announces Achievement of Key Milestones for its Clinical Stage MEK Inhibitor Compound.".